Mechanisms of Thrombocytopenia in Dogs with Cancer

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 22, Issue 11, 2000, Pages 1006-1017

  Chisholm Chait, Alexandra ^a,b  

^a AUBURN UNIVERSITY   (United States)

^b Pet Emergency and Specialty Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347794936     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (91)

1. Sun NCJ, McAfee WM, Hum GJ, et al: Hemostatic abnormalities in malignancy, a prospective study of 108 patients. Part I. Coagulation studies. Am J Clin Pathol 71:10-16, 1979.
2. Madewell BR, Feldman BF, O'Neill S, et al: Coagulation abnormalities in dogs with neoplastic disease. Thromb Haemost 44:35-38, 1980.
3. Rasche H, Dietrich M: Hemostatic abnormalities associated with malignant disease. Eur J Cancer 23:1053-1064, 1977.
4. Grindem CB, Breitschwerdt EB, Corbett WT, et al: Thrombocytopenia associated with neoplasia in dogs. J Vet Intern Med 8(6):400-405, 1994.
5. O'Donnell MR, Slichter SJ, Weiden PL, et al: Platelet and fibrinogen kinetics in canine tumors. Cancer Res 41:1379-1383, 1981.
6. Madewell BR: Hematological and bone marrow cytological abnormalities in 75 dogs with malignant lymphoma. JAAHA 22:235-240, 1986.
7. Hammer AS, Couto CG, Swardson C, et al: Hemostatic abnormalities in dogs with hemangiosarcoma. J Vet Intern Med 5(1):11-14, 1991.
8. Hargis AM, Feldman BF: Evaluation of hemostatic defects secondary to vascular tumors in dogs: 11 cases (1983-1988). JAVMA 198:891-895, 1991.
9. Broxmeyer HE, Jacobsen N, Kurland J, et al: In vitro suppression of normal granulocytic stem cells by inhibitory activity derived from human leukemia cells. J Natl Cancer Inst 60:497-511, 1978.
10. Helfand SC: Platelets and neoplasia. Vet Clin North Am Small Anim Clin 18:131-156, 1988.
11. Zucker S: Anemia associated with foreign cells in the marrow (myelophthisis), in Lichtman MA (ed): Hematology and Oncology. New York, Grune & Stratton, 1980, p 42.
12. Broxmeyer HE: Acidic isoferritins as suppressor molecules [letter]. Blood 68:796-797, 1986.
13. Homans AC, Cohen JL, Barker BE, Mazur EM: Aplastic presentation of acute lymphoblastic leukemia: Evidence for cellular inhibition of normal hematopoietic progenitors. Am J Pediatr Hematol Oncol 11 (4):456-462, 1989.
14. Broxmeyer HE, Grossbard E, Jacobsen N, et al: Persistence of inhibitory activity against normal bone marrow cells during remission of acute leukemia. N Engl J Med 301:346-351, 1979.
15. Thrall MA: Lymphoproliferative disorders: Lymphocytic leukemia and plasma cell myeloma. Vet Clin North Am Small Anim Pract 11:321-347, 1981.
16. Cain GR, Feldman BF, Kawakami TG, Jain NC: Platelet dysplasia associated with megakaryoblastic leukemia in a dog. JAVMA 188:529-530, 1986.
17. Couto CG, Kallet AJ: Preleukemic syndrome in a dog. JAVMA 184:1389-1392, 1984.
18. Harvey JW: Myeloproliferative disorders in dogs and cats. Vet Clin North Am Small Anim Pract 11:349-381, 1981.
19. Maggio L, Hoffman R, Cotter SM, et al: Feline pre-leukemia: An animal model of human disease. Yale J Biol Med 51:469-476, 1978.
20. Spier SJ, Madewell BR, Zinkl JG, et al: Acute myelomonocytic leukemia in a horse. JAVMA 188:861-863, 1986.
21. Galton DAG: The myelodysplastic syndromes. Scand J Haematol 36:11-20, 1986.
22. Linman JW, Bagby Jr GC: The preleukemic syndrome (hematopoietic dysplasia). Cancer 42:854-864, 1978.
23. Sherding RG, Wilson III GP, Kociba GJ: Bone marrow hypoplasia in eight dogs with Sertoli cell tumors. JAVMA 178:497-501, 1981.
24. Moulton JE: Tumors of the genital system, in Moulton JE (ed): Tumors in Domestic Animals, ed 2. Berkeley, University of California Press, 1978, pp 309-345.
25. Schalm OW, Jain NC, Carroll EJ: The blood platelets, in Veterinary Hematology, ed 3. Philadelphia, Lea & Febiger, 1975, pp 336-355.
26. Schalm OW: Exogenous estrogen toxicity in the dog. Canine Pract 5:57-61, 1978.
27. Levin J: Chemotherapy and thrombopoiesis, in Brodsky I et al (eds): Cancer Chemotherapy III: Forty-Sixth Hahnemann Symposium. New York, Grune & Stratton, 1978, pp 313-325.
28. Schwartz KA, Slichter SJ, Harker LA: Immune-mediated platelet destruction and thrombocytopenia in patients with solid tumors. Br J Haematol 51:17-24, 1982.
29. Helfand SC, Couto CG, Madewell BR, et al: Immune-mediated thrombocytopenia associated with solid tumors in dogs. JAAHA 21:787-794, 1985.
30. Antman KH, Skarin AT, Mayer RJ, et al: Microangiopathic hemolytic anemia and cancer: A review. Medicine 58:377-384, 1979.
31. DeBruyere M, Sokal G, Devoitille JM, et al: Autoimmune haemolytic anaemia and ovarian tumor. Br J Haematol 20:83-94, 1971.
32. Thpofilopoulos AN, Andrews BJ, Urist MM, et al: The nature of immune complexes in human cancer. J Immunol 119:657-663, 1977.
33. DeBoer DJ, Madewell BR: Detection of immune complexes in serum of dogs with neoplastic disease by solid-phase Clq binding, using an enzyme-linked immunosorbent assay. Am J Vet Res 44:1710-1713, 1983.
34. Kristensen AT, Weiss DJ, Klausner JS, et al: Platelet dysfunction associated with immune-mediated thrombocytopenia in dogs. J Vet Intern Med 8:323-327, 1994.
35. Vazquez JJ, Lewis JH: Immunocytochemical studies on platelets. The demonstration of a common antigen in human platelets and megakaryocytes. Blood 16:968-976, 1960.
36. Joshi BC, Jain NC: Detection of antiplatelet antibody in serum and on megakaryocytes of dogs with autoimmune thrombocytopenia. Am J Vet Res 37:681-685, 1976.
37. Murtaugh RJ, Jacobs RM: Suspected immune-mediated megakaryocytic hypoplasia or aplasia in a dog. JAVMA 186:1313-1315, 1985.
38. Campbell KL, George JW, Greene CE: Application of the enzyme-linked immunosorbent assay for the detection of platelet antibodies in dogs. Am J Vet Res 45:2561-2564, 1984.
39. Davenport DJ, Breitschwerdt EB, Carakostas MC: Platelet disorders in the dog and the cat. Part I. Physiology and pathogenesis. Compend Contin Educ Pract Vet 4(9):762-772, 1982.
40. Davenport DJ, Breitschwerdt EB, Carakostas MC: Platelet disorders in the dog and the cat. Part II. Diagnosis and management. Compend Contin Educ Pract Vet 4(10):788-796, 1982.
41. Brain MC: Microangiopathic hemolytic anemia. Annu Rev Med 21:133-144, 1970.
42. Boughton B, Allington M, King A: Platelet and plasma beta-thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis. Br J Haematol 40:125-132, 1978.
43. Madewell BR, Feldman BF: Characterization of anemias associated with neoplasia in small animals. JAVMA 176:419-425, 1980.
44. Slichter SJ, Harker LA: Hemostasis in malignancy. Ann NY Acad Sci 230:252-261, 1974.
45. Marcum JM, McGill M, Jamieson GA: Platelet-tumor cell-vessel wall interactions in vitro. Blood 54(Suppl):251a, 1979.
46. Ausprunk DH, Folkman J: Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14:53-65, 1977.
47. Gasic GJ, Gasic TB, Galanti N, et al: Platelet-tumor cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer 11:704-718, 1973.
48. Feldman BF: Coagulopathies in small animals. JAVMA 179:559-563, 1981.
49. Rishniw M, Lewis D: Localized consumptive coagulopathy associated with cutaneous hemangiosarcoma in a dog. JAAHA 30:261, 1994.
50. Warrel RP, Kempin SJ, Benua RS, et al: Intratumoral consumption of indium-111 labeled platelets in a patient with hemangiomatosis and intravascular coagulation (Kasabach-Merritt syndrome). Cancer 52:2256-2260, 1983.
51. Warrel RP, Kempin SJ: Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproid acid and cryoprecipitate. N Engl J Med 313:309-312, 1985.
52. Bick RL: Disseminated intravascular coagulation and related syndromes. A review. Semin Thromb Haemost 14:299-330, 1988.
53. Yahara Y, Okawa S, Oncozawa Y: Activation of platelets in cancer, especially with reference to genesis of disseminated intravascular coagulation. Thromb Res 29:27-35, 1983.
54. Lee LH, Baglin T: Altered platelet phospolipid-dependent thrombin generation in thrombocytopenia and thrombocytosis. Br J Haematol 89:131-136, 1995.
55. Landolfl R, De Cristofaro R, Castagnola M, et al: Increased platelet fibrinogen affinity in patients with myeloproliferative disorders. Blood 71:978-982, 1988.
56. Bick RL, Strauss JF, Frenkel EP: Thrombosis and hemorrhage in oncology patients. Hematol Oncol Clin North Am 10(4):876-907, 1996.
57. Bick RL: Alterations of hemostasis in malignancy, in Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice, Chicago, ASCP Press, 1992, p 239.
58. Cliffron EE, Gross CE: Fibrinolytic activity of human tumors as measured by the fibrinplate method. Cancer 8:1146, 1955.
59. Bick RL: Alterations of hemostasis in malignancy, in Bick RL, Bennett JM, Brynes RK (eds): Hematology: Clinical and Laboratory Practice. St. Louis, Mosby, 1993, p 1583.
60. Bick RL: Alterations of hemostasis associated with malignancy: Etiology, pathophysiology, diagnosis and management. Semin Thromb Hemost 1:5, 1978.
61. Pineo GF, Brain MC, Gallus AS: Tumors, mucus production, and hypercoagulability. Ann NY Acad Sci 230:262, 1974.
62. Pineo GF, Regorczi F, Hatton MW: The activation of coagulation by extracts of mucin: A possible pathway of intravascular coagulation accompanying adenocarcinomas. J Lab Clin Med 82:255, 1973.
63. Lisiewicz J: Mechanisms of hemorrhage in leukemias. Semin Thromb Hemost 4:241, 1978.
64. Lisiewicz J: Disseminated intravascular coagulation in acute leukemia. Semin Thromb Hemost 14:339, 1988.
65. Boggs DR, Wintrobe MM, Cartwright CE: Acute leukemias: Analysis of 322 cases and review of the literature. Medicine 41:163, 1962.
66. Coleman RW, Rubin RN: Disseminated intravascular coagulation due to malignancy. Semin Oncol 17:172-186, 1990.
67. Gordon S: Cancer cell procoagulants and their implications. Hematol Oncol Clin North Am 6(6):1359, 1992.
68. Francis JL: Haemostasis and cancer. Med Lab Sci 46:331, 1989.
69. Gordon SG, Franks JJ, Lewis BJ: Comparison of procoagulant activities in extracts of normal and malignant human tissue. J Natl Cancer Inst 62:773, 1979.
70. Gordon SG, Lewis BJ: Comparison of procoagulant activity in tissue culture medium from normal and transformed fibroblasts. Cancer Res 38:2467, 1978.
71. Gordon SG, Benson B: Analysis of serum cancer procoagulant activity and its possible use as a tumor marker. Thromb Res 56:431, 1989.
72. Gordon SG, Cross BA: An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker. Cancer Res 50:6229, 1990.
73. Donati MB, Falanga A, Consonni R, et al: Cancer procoagulant in acute non lymphoid leukemia: Relationship of enzyme detection to disease activity. Thromb Haemost 64:11, 1990.
74. Valkov J: Histologic studies of extramedullary hemopoiesis in leukemias and its relationship to the blood vessels. Med Fizkult 42:35, 1963.
75. O'Keefe DA, Couto CG: Coagulation abnormalities associated with neoplasia. Vet Clin North Am Small Anim Clin 18:157-168, 1988.
76. Rogers KS: Coagulation disorders associated with neoplasia in the dog. Vet Med 87(1):55-61, 1992.
77. Fabris F, Casonato A, Del Ben MG: Abnormalities of von Willebrand factor in myeloproliferative disease: A relationship with bleeding diatheses. Br J Haematol 63:75, 1986.
78. Rosenberg RD, Green DM: The hemostatic process and neoplastic disease, in Holland JF, Frei E (eds): Cancer Medicine, Philadelphia, Lea & Febiger, 1982, pp 1326-1338.
79. Shepard VJ, Dodds-Laffin WJ, Laffin RJ: Gamma A myeloma in a dog with defective hemostasis. JAVMA 160:102-104, 1972.
80. Jacobs RM, Boyce JT, Kociba GJ: Flow cytometric and radioisotopic determinations of platelet survival time in normal cats and feline leukemia virus-infected cats. Cytometry 7:64-69, 1986.
81. MacEwen EG, Hurvitz AI: Diagnosis and management of monoclonal gammopathies. Vet Clin North Am Small Anim Pract 7:119-132, 1977.
82. Williams DA: Gammopathies. Compend Contin Educ Pract Vet 3(9):815-822, 1981.
83. Perkins HA, MacKenzie MR, Fudenberg HH: Hemostatic defects in dysproteinemias. Blood 35:695-707, 1970.
84. Rasi V, Lintula R. Platelet function in the myelodysplastic syndromes. Scand Haematol 36:71-73, 1986.
85. Dodds WJ: Hereditary and acquired hemorrhagic disorders in animals, in Spaet TH (ed): Progress in Hemostasis and Thrombosis, vol 2. New York, Grune & Stratton, 1974, pp 215-247.
86. O'Keefe DA, Couto CG, Jacobs RM, et al: Systemic mastocytosis in 16 dogs. J Vet Intern Med 1:75-80, 1987.
87. Weick JK. Intravascular coagulation in cancer: Semin Oncol 5:203-211, 1978.
88. Thatcher LG, Clatanoff DV, Steihm ER: Splenic hemangioma with thrombocytopenia and afibrinogenemia. J Pediatr 73:345-354, 1981.
89. Johnson KA, Powers BE, Withrow SJ, et al: Splenomegaly in dogs: Predictors of neoplasia and survival after splenectomy. J Vet Intern Med 3:160-166, 1989.
90. Ichikawa N, Ishida F, Shimodaira S, et al. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura. Thromb Haemost 76(2):156-160, 1996.
91. Kuter DJ, Rosenberg RD: The reciprocal relationship of thrombopoietin (c-mpl ligand) to changes in the mean platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 85:2720, 1995.